Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Titel:
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Auteur:
Muro, Kei Chung, Hyun Cheol Shankaran, Veena Geva, Ravit Catenacci, Daniel Gupta, Shilpa Eder, Joseph Paul Golan, Talia Le, Dung T Burtness, Barbara McRee, Autumn J Lin, Chia-Chi Pathiraja, Kumudu Lunceford, Jared Emancipator, Kenneth Juco, Jonathan Koshiji, Minori Bang, Yung-Jue